The effectiveness of both carnitine formulation in preventing upregulation of SIRT1, SIRT3, and SOD2 proteins is a strong indication that carnitine alleviates PCOS altered redox milieu. This evidence concerns the gene SIRT3 and polycystic ovary syndrome.